FMS241220C15000
- 0.00
- 0.000.00%
Fresenius Medical Care Newsroom
Institutional Investors Control 42% of Fresenius Medical Care AG (ETR:FME) and Were Rewarded Last Week After Stock Increased 6.1%
Berenberg Bank Keeps Their Buy Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Care AG & Co. KGaA (0H9X) Receives a Buy From Goldman Sachs
Top Gap Ups and Downs on Tuesday: ACN, DB, X and More
J.P. Morgan Reaffirms Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
BofA Securities Upgrades Fresenius Medical Care(FMS.US) to Hold Rating
Fresenius Medical Care (FMS) Gets a Hold From Bank of America Securities
Cautious Optimism: Hold Rating for Fresenius Medical Care Amid Structural Challenges and Valuation Reflections
European Equities Traded in the US as American Depositary Receipts Advance Friday
Fresenius Medical Care AG's (ETR:FME) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement With Premier, Inc. for the Novalung ECMO System
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA
Fresenius Medical Care's AI-Powered Application of the Anemia Control Model Selected for CMS AI Demo Days in the United States
Top Gap Ups and Downs on Friday: NVO, HSBC, AMAT and More
Medtech Shouldn't Be Greatly Impacted by RFK Jr. at HHS, Wells Fargo Says
Assessing MedTech Impact From Potential China Tariffs
Kepler Capital Reaffirms Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
Fresenius Medical Q3 Earnings Beat Estimates, Operating Margin Rises
Truist Financial Maintains Fresenius Medical Care(FMS.US) With Hold Rating, Maintains Target Price $23
Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Fresenius Medical Care (FMS) and Treace Medical Concepts (TMCI)